logo

Anavex Life Sciences Corp. (AVXL)



Trade AVXL now with
  Date
  Headline
6/21/2021 7:10:58 AM Anavex: ANAVEX2-73 Biomarker Correlated With Efficacy Endpoints In US Phase 2 Trial
6/8/2021 7:13:59 AM Anavex Says Exceeded Enrollment Target For ANAVEX 2-73 Phase 2b/3 Study In Alzheimer's Disease
5/26/2021 7:06:31 AM Anavex Life Sciences Appoints Jiong Ma To Board
10/15/2020 7:11:49 AM Anavex Life Sciences Announces Positive Results From Proof Of Concept Controlled Phase 2 Clinical Trial Of ANAVEX®2-73
7/6/2020 7:11:16 AM Anavex Says First Participant Enrolled In Phase 1 Study Of ANAVEX3-71
7/1/2020 7:12:52 AM Anavex Says First Patient Dosed In EXCELLENCE Phase 2/3 ANAVEX2-73-RS-003 Clinical Trial
6/16/2020 7:18:30 AM Anavex Exceeds Enrollment Target For ANAVEX 2-73 U.S. Phase 2 Rett Syndrome Clinical Trial
6/4/2020 7:19:12 AM Anavex Life Sciences Gets Approval From Health Canada & UK MHRA Expanding Phase 2b/3 ANAVEX2-73 Into Multinational Trial
5/21/2020 7:15:25 AM Anavex Life Sciences Initiates First-in-Human Phase 1 Study Of ANAVEX®3-71
2/3/2020 7:10:27 AM Anavex Life Sciences: FDA Grants Fast Track Designation For ANAVEX®2-73 Clinical Development Program For Rett Syndrome